Meanwhile, to verify the clinical potential of targeting Lgals3 for treatment of kidney stones, we established another CaOx crystal mouse model according our previous studies by injecting glycolic acid for consecutively 12 days and inhibited Lgals3 through MCP and GB1107 (Figure S10A, Supporting Information). The gene discussed is LGALS3; the disease is nephrolithiasis.